Steve Melvyn Howdle
Voorzitter bij The University of Nottingham
Actieve functies van Steve Melvyn Howdle
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of Nottingham | Voorzitter | - | - |
Loopbaan van Steve Melvyn Howdle
Eerdere bekende functies van Steve Melvyn Howdle
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 | - |
| Oprichter | 01-01-2002 | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Chairman | 1 |
Sectoraal
| Consumer Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Steve Melvyn Howdle
- Ervaring
